GlassScriptPhysician profile
David Rhyne
NPI 1285627109
$4,366.08
in general payments reported to CMS, 2019-2025
34 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,013 · 2020: $1,389 · 2021: $964.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $510.36 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $499.54 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $409.45 | 2019-2021 | |
| Abbvie INC. | $331.32 | 2019-2021 | |
| Allergan, INC. | $311.11 | 2019-2020 | |
| Pfizer INC. | $272.96 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $235.11 | 2019-2021 | |
| Amarin Pharma, INC. | $217.81 | 2019-2021 | |
| Corcept Therapeutics | $186.12 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $175.76 | 2019-2021 | |
| Amgen INC. | $154.83 | 2019-2021 | |
| Novo Nordisk INC | $124.36 | 2019-2021 | |
| Lilly USA, LLC | $119.05 | 2019 | |
| Merck Sharp & Dohme LLC | $115.28 | 2019 | |
| Esperion Therapeutics, INC. | $98.97 | 2020-2021 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceuticals, INC. | $89.71 | 2021 | |
| Ironwood Pharmaceuticals, INC | $81.83 | 2019-2020 | |
| Nestle Healthcare Nutrition INC. | $67.90 | 2020-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $52.91 | 2019-2021 | |
| Mylan Specialty L.P. | $51.32 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $40.58 | 2019-2020 | |
| Astellas Pharma US INC | $32.65 | 2019 | |
| Eisai INC. | $29.91 | 2020-2021 | |
| Emmaus Medical, INC. | $21.30 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $17.47 | 2019 | |
| Aytu Biopharma, INC. | $16.25 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $15.24 | 2021 | |
| Upsher-Smith Laboratories LLC | $14.52 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $13.82 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $12.56 | 2020 | |
| Acadia Pharmaceuticals INC | $12.25 | 2019 | |
| Biodelivery Sciences International, INC. | $11.33 | 2020 | |
| Shire North American Group INC | $11.29 | 2019 | |
| Hologic Sales and Service, LLC | $11.21 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Rhyne listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.